Latest News

Date Title Topic
26 Jan 2015 ESMO Press Release: ESMO Delivers on Dynamic Force Strategy to Improve Cancer Research in Europe Bioethics, legal and economic issues
26 Jan 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Protein Bound Paclitaxel Lung and other thoracic tumours - Anticancer agents & Biologic therapy
22 Jan 2015 Successful Implementation of SPECTAcolor, the First Pan-European and EORTC Screening Platform, Proves that a Logistically Complex Infrastructure to Run Next Generation Trials in a Multinational Setting is Feasible Personalised medicine - Translational research - Gastrointestinal cancers
ESMO – ACP
ESMO – SLO
20 Jan 2015 First-Line FOLFOXIRI/Bevacizumab Improves Long-Term Outcomes in Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
19 Jan 2015 Second-Line Treatment with FOLFIRI/Ramucirumab Delays Disease Progression and Extends Overall Survival in Patients With Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
16 Jan 2015 Next Generation Sequencing Reveals Genetic Landscape of Breast Phyllodes Tumours Breast cancer - Translational research
14 Jan 2015 Many Cancer Survivors Have Unmet Physical and Mental Needs Palliative and supportive care
11 Feb 2015 Image of the Month
08 Jan 2015 Statistical Modeling Links Cancer Risk With Number of Stem Cell Divisions Translational research
07 Jan 2015 International Conference on Head and Neck Cancer 2015
05 Jan 2015 FDA Approves Nivolumab for Patients with Advanced, Refractory Melanoma Melanoma - Immuno-oncology